Prospective clients with abnormally skinny skin or pores and skin atrophy, such as viewed in corticosteroid-induced atrophy in the pores and skin resulting from lengthy-phrase topical or peroral steroid use, or with circumstances including anetoderma, vermiculate atrophoderma, or rheumatoid arthritis-associated skin thinning from the dorsum in the